Position in ABT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$62,968,537
-$13,368,154 QoQ
Shares Held
613,310
+0.7% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Cetera Investment Advisers holds $248,574,257 across 33 Medical Devices names. ABT ranks #1 (25.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
This page
|
613,310 | $62,968,537 | |
| 2 | MDT |
Medtronic plc
|
696,767 | $60,374,860 | |
| 3 | SYK |
Stryker Corp
|
151,677 | $49,839,545 | |
| 4 | BSX |
Boston Scientific Corp
|
473,400 | $29,705,850 | |
| 5 | DXCM |
Dexcom Inc
|
128,775 | $8,087,070 | |
| 6 | EW |
Edwards Lifesciences Corp
|
83,953 | $6,722,956 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
85,908 | $6,114,931 | |
| 8 | GMED |
Globus Medical Inc
|
42,497 | $3,661,541 |
All Filings in ABT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $62,968,537 | 613,310 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $76,336,691 | 609,280 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $78,336,416 | 584,862 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $55,606,464 | 408,841 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $51,045,577 | 384,814 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $42,275,428 | 373,755 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $43,486,036 | 381,423 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $43,104,777 | 414,828 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $53,454,070 | 470,298 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $13,867,939 | 125,992 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $12,483,965 | 128,900 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $13,708,065 | 125,739 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $13,101,525 | 129,385 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $15,154,643 | 138,033 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $56,504,356 | 583,964 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $33,448,771 | 307,858 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $36,494,648 | 308,336 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $42,998,462 | 305,517 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $35,900,415 | 303,906 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $35,161,569 | 303,300 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $35,556,288 | 296,698 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $11,308,565 | 103,284 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $2,161,254 | 19,859 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,798,428 | 19,670 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,673,128 | 21,203 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||